Patients News | pharmaphorum

News

Study finds low secondary cancer risk with CAR-Ts

There’s no doubt that CAR-T therapies have transformed the treatment of many blood cancers, but a risk of secondary malignancies has cast a pall over the class.

News

Telehealth firm fraud charges may worsen ADHD drug shortage

Two executives at a telehealth start-up have been arrested and are facing allegations of fraud involving the distribution of medicines for attention-deficit hyperactivity disorder (ADHD).

News

DeepWell gamifies breathing therapy for mental health

Studies have shown that controlled breathing exercises may help to reduce stress and improve mental health, leading to a surge in public interest in activities like meditation that can deli

News

SCOTUS rejects challenge to abortion pill mifepristone

The Supreme Court has rejected a lawsuit challenging the authority of the FDA to regulate the abortion pill mifepristone, in a move that will ensure it can still be provided by mail-order w

News

Future of Pfizer’s Duchenne gene therapy in doubt

Pfizer is “evaluating appropriate next steps” for its Duchenne muscular dystrophy (DMD) gene therapy after it failed a phase 3 trial.

News

GSK et al file appeal to Delaware Zantac order

GSK and other drugmakers have lost no time in filing an appeal to a Delaware court’s decision to allow more than 70,000 Zantac-related lawsuits to go ahead.

Study finds low secondary cancer risk with CAR-Ts

Telehealth firm fraud charges may worsen ADHD drug shortage

DeepWell gamifies breathing therapy for mental health

SCOTUS rejects challenge to abortion pill mifepristone

Future of Pfizer’s Duchenne gene therapy in doubt

GSK et al file appeal to Delaware Zantac order

Making direct-to-patient work, with Matt Wadyka

Using AI-driven synthetic personas to take your insights fur...

News

Editor's Picks